|
| Status |
Public on Jan 18, 2021 |
| Title |
The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer [PDX model HCI-005 & GAR15-13 RNA-seq] |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
The role of the androgen receptor (AR) in estrogen receptor alpha (ER) positive breast cancer is controversial, constraining implementation of AR-directed therapies. Using a diverse, clinically relevant panel of cell-line and patient-derived models, we demonstrate that AR activation, not suppression, exerts potent anti-tumor activity in multiple disease contexts, including resistance to standard-of-care ER and CDK4/6 inhibitors. Importantly, AR agonists combined with standard-of-care agents enhanced therapeutic responses. Mechanistically, agonist activation of AR altered the genomic distribution of ER and essential co-activators (p300, SRC-3), resulting in repression of ER-regulated cell cycle genes and up-regulation of AR target genes, including known tumor suppressors. A gene signature of AR activity positively predicted disease survival in multiple clinical ER+ breast cancer cohorts. These findings provide unambiguous evidence that AR has a tumor suppressor role in ER+ breast cancer and support AR agonism as the optimal AR-directed treatment strategy, revealing a rational therapeutic opportunity.
|
| |
|
| Overall design |
RNA-seq of patient-derived xenograft (PDX) tumor models HCI-005 & GAR15-13 treated for 5 days with either Vehicle, DHT, or Enobosarm.
|
| |
|
| Contributor(s) |
Hickey TE, Selth LA, Chia KM, Milioli HH, Roden D, Laven-Law G, Lim W, Tilley WD |
| Citation(s) |
33462444 |
| Submission date |
Dec 13, 2018 |
| Last update date |
Jan 26, 2021 |
| Contact name |
Luke Selth |
| E-mail(s) |
luke.selth@flinders.edu.au
|
| Organization name |
Flinders University
|
| Department |
College of Medicine and Public Health
|
| Street address |
Flinders Drive
|
| City |
Bedford Park |
| State/province |
SA |
| ZIP/Postal code |
5042 |
| Country |
Australia |
| |
|
| Platforms (1) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
| Samples (24)
|
|
| This SubSeries is part of SuperSeries: |
| GSE123770 |
The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer |
|
| Relations |
| BioProject |
PRJNA509776 |
| SRA |
SRP173367 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE123763_Gar15-13_Veh_Sarm_DHT.edgeR.fc.txt.gz |
301.0 Kb |
(ftp)(http) |
TXT |
| GSE123763_Gar15-13_Veh_Sarm_DHT.matrix.txt.gz |
850.9 Kb |
(ftp)(http) |
TXT |
| GSE123763_Gar15-13_Veh_vs_DHT_results.csv.gz |
112.4 Kb |
(ftp)(http) |
CSV |
| GSE123763_HCI-005_Veh_Sarm_DHT.edgeR.fc.txt.gz |
225.2 Kb |
(ftp)(http) |
TXT |
| GSE123763_HCI-005_Veh_Sarm_DHT.matrix.txt.gz |
594.5 Kb |
(ftp)(http) |
TXT |
| GSE123763_HCI-005_Veh_v_DHT_results.csv.gz |
111.4 Kb |
(ftp)(http) |
CSV |
| GSE123763_RPKM_Gar15-13.csv.gz |
1.6 Mb |
(ftp)(http) |
CSV |
| GSE123763_RPKM_HCI-005.csv.gz |
1.2 Mb |
(ftp)(http) |
CSV |
SRA Run Selector |
| Raw data are available in SRA |
| Processed data are available on Series record |
Less...
More...